Biography
Xingdong Ye has his passion in improving the health and wellbeing, graduated from Jiangxi Gannan School of Medicine, China in 1988, and got his Master's degree in Sun Yatsum Medical University, Guangzhou in 1995, engaged in the prevention and treatment of syphilis. More than 100 professional academic papers had been published in the past decades and he has put forward to the prevention and control of syphilis in Guangzhou with his proposal entiled “1234†basic strategies after finishing the Guangzhou municipal major project on syphilis control, and reported application of nested quantitative PCR in detecting TP DNA in the diagnosis of syphilis from various biological samples for the first time.
Abstract
Though finding of T. palladium in dark field microscope or positive specific and nonspecific T. pallidium antibody was enough to make a diagnosis of syphilis, determination of early infection was a challenge at present. Polymerase chain reaction (PCR) was essential for syphilis diagnosis for those with negative serum antibody and organism as well. We reported that detection limit was 2 TP /ml for nest-real time-PCR (NR-PCR) (Fig.1), the present work is to evaluate application of NR-PCR in the detection of TP DNA from various biological samples of syphilitic patients. A total of 923 various samples including tissue swabs, serum the whole blood, earlobe blood and CSF were collected from 576 patients. Of those, 43 swabs from early syphilis lesions were detected for TP DNA by both Nest PCR (nPCR) and NR-PCR, the sensitivity of TP DNA detection by nPCR and NR-PCR was 79% (34/43), 72% (31/43) respectively, kappa was .81. The TP DNA positive rate for earlobe blood collected from latent syphilis and neurosyphilis were 70.3%, 26.7% respectively, and a significant difference was observed (P<0.01). TP DNA positive rate detected by NR PCR for swabs, serum, whole blood collected during initiate visit was 84.2%, 66.9%, 42.4% respectively. In patients with positive TPPA, the sensitivity, specificity, positive predictive value, negative predictive value for NR PCR in detecting TP DNA in blood of primary stage was 72.5%, 75%, 99.6%, 2.9% respectively, and Youden index 0.48, kappa value 0.024 (Table 1), least agreement was shown between NR PCR and syphilitic serological results in making syphilis diagnosis (P<0.03). It was concluded that the TP DNA positive rate for different samples group in various type syphilis was different from each other when detected by NR-PCR, and there is less agreement between syphilitic serology diagnosis and NR-PCR in making syphilis diagnosis. They can be independently used clinically.
Biography
M Shakirzyanova is a licensed Medical Laboratory Scientist with a PhD in Microbiology and a research background in Virology, Molecular Biology and Microbiology. During her Post-doctoral Fellowship, she studied HIV transmission and monitored SAIDS in monkey (Indian Rhesus Macaque) model. She conducted analysis of the co-receptor switch in R5-tropic SHIV-infected macaques. She has expertise in protocol development, reporting, and analysis of experimental data. Her current research is monitoring of HIV-1 drug resistance in HIV-1 positive patients on anti-retroviral therapy.
Abstract
Statement of the Problem: Integrase strand transfer inhibitors together with protease and reverse transcriptase inhibitors are the drugs recommended by NIH for pre- and post- HIV-1 exposure prophylaxis. As part of the Ending the AIDS Epidemic (ETE) initiative in New York State, the NYC Public Health Laboratory has validated the ViroSeq HIV-1 Integrase Genotyping Assay for detection of the drug resistance mutations in the HIV-1 integrase gene. This assay allows us to provide the clinicians with complete drug resistance information. Meanwhile, the sequence data allows performing the phylogenetic analysis of virus from newly infected patients and following up of incident cases that may be out of care. Methods: RNA was isolated manually from plasma samples (provided by NYC VA Hospital and Sonic Reference Laboratory Austin, TX), or recombinant viruses’ supernatants (Harvard Medical School). The viral DNA was amplified by RT-PCR, quantified on agarose gel, purified, and used for cycle sequencing PCR. The sequencing was performed on ABI3500 genetic analyzer. Results: The limit of detection results were generated with four randomly chosen supernatants diluted at several levels with negative human plasma. The LOD was 500 gene copies per mL (cp/ml) for two of the supernatants (Y143C; V151I and L74M, V151I, N155H), 1000 gene cp/ml for one (G140S; Q148H; V151I), and 2500 gene cp/ml for another one (V151I, N155H and G163R). The reproducibility was performed with virus harboring E92Q/N155H/V151I mutations. All sequencing results showed the same mutations at different dilution levels, which confirmed the high reproducibility of the assay. Blinded sample validation was performed on 40 samples. All of drug resistance mutations revealed in our study was matched with the keys provided by the supplier of the samples. Conclusion: ViroSeq HIV-1 Integrase Genotyping Assay detects integrase resistant mutations with the reasonable analytical sensitivity, and the high reproducibility and 100% accuracy.